Logo_Icesi
 

Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants

dc.audienceComunidad Universidad Icesi – Investigadoresspa
dc.citation.issue8
dc.citation.volume3
dc.contributor.authorDanaei, Goodarzspa
dc.coverage.spatialLondres de Lat: 51 30 51 N degrees minutes Lat: 51.5142 decimal degrees Long: 000 05 35 W degrees minutes Long: -0.0931 decimal degrees
dc.date.accessioned2017-07-06T16:45:46Z
dc.date.available2017-07-06T16:45:46Z
dc.date.issued2015-08-01
dc.description.abstractBackground: Diabetes has been defined on the basis of different biomarkers, including fasting plasma glucose (FPG), 2-h plasma glucose in an oral glucose tolerance test (2hOGTT), and HbA<inf>1c</inf>. We assessed the effect of different diagnostic definitions on both the population prevalence of diabetes and the classification of previously undiagnosed individuals as having diabetes versus not having diabetes in a pooled analysis of data from population-based health examination surveys in different regions. Methods: We used data from 96 population-based health examination surveys that had measured at least two of the biomarkers used for defining diabetes. Diabetes was defined using HbA<inf>1c</inf> (HbA<inf>1c</inf> ≥6·5% or history of diabetes diagnosis or using insulin or oral hypoglycaemic drugs) compared with either FPG only or FPG-or-2hOGTT definitions (FPG ≥7·0 mmol/L or 2hOGTT ≥11·1 mmol/L or history of diabetes or using insulin or oral hypoglycaemic drugs). We calculated diabetes prevalence, taking into account complex survey design and survey sample weights. We compared the prevalences of diabetes using different definitions graphically and by regression analyses. We calculated sensitivity and specificity of diabetes diagnosis based on HbA<inf>1c</inf> compared with diagnosis based on glucose among previously undiagnosed individuals (ie, excluding those with history of diabetes or using insulin or oral hypoglycaemic drugs). We calculated sensitivity and specificity in each survey, and then pooled results using a random-effects model. We assessed the sources of heterogeneity of sensitivity by meta-regressions for study characteristics selected a priori. Findings: Population prevalence of diabetes based on FPG-or-2hOGTT was correlated with prevalence based on FPG alone (r=0·98), but was higher by 2-6 percentage points at different prevalence levelseng
dc.format.extent14 páginasspa
dc.format.mediumDigitalspa
dc.format.mimetypeapplication/pdf
dc.identifier.doihttp://dx.doi.org/10.1016/S2213-8587(15)00129-1
dc.identifier.instnameinstname:Universidad Icesi
dc.identifier.issn2213-8587
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84938199196&doi=10.1016%2fS2213-8587%2815%2900129-1&partnerID=40&md5=165bb4fcc5d56b5f57ef4fb86cf6075f
dc.identifier.reponamereponame:Biblioteca Digital
dc.identifier.repourlrepourl:https://repository.icesi.edu.co/
dc.identifier.urihttp://hdl.handle.net/10906/81710
dc.language.isoeng
dc.publisherLancet Publishing Group
dc.publisher.departmentDepartamento de Ciencias Básicas Médicasspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.placeLondresspa
dc.publisher.programMedicinaspa
dc.relation.citationendpage637
dc.relation.citationstartpage624
dc.relation.ispartofThe Lancet Diabetes and Endocrinology, Vol.3, No.8 - 2015
dc.rightsEL AUTOR, expresa que la obra objeto de la presente autorización es original y la elaboró sin quebrantar ni suplantar los derechos de autor de terceros, y de tal forma, la obra es de su exclusiva autoría y tiene la titularidad sobre éste. PARÁGRAFO: en caso de queja o acción por parte de un tercero referente a los derechos de autor sobre el artículo, folleto o libro en cuestión, EL AUTOR, asumirá la responsabilidad total, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos, la Universidad Icesi actúa como un tercero de buena fe. Esta autorización, permite a la Universidad Icesi, de forma indefinida, para que en los términos establecidos en la Ley 23 de 1982, la Ley 44 de 1993, leyes y jurisprudencia vigente al respecto, haga publicación de este con fines educativos. Toda persona que consulte ya sea la biblioteca o en medio electrónico podrá copiar apartes del texto citando siempre la fuentes, es decir el título del trabajo y el autor.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesseng
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.proposalMedical scienceseng
dc.subject.proposalGlucose bloodeng
dc.subject.proposalBiological markereng
dc.subject.proposalGlucoseeng
dc.subject.proposalCiencias socio biomédicasspa
dc.subject.proposaldiabetesspa
dc.subject.proposalGlucosaspa
dc.titleEffects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driverinfo:eu-repo/semantics/articleeng
dc.type.localArtículo
dc.type.versioninfo:eu-repo/semantics/publishedVersioneng

Archivos

Bloque original

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
guerrero_effects_diabetes_2015.pdf
Tamaño:
377.49 KB
Formato:
Adobe Portable Document Format